全文获取类型
收费全文 | 1601篇 |
免费 | 63篇 |
国内免费 | 48篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 43篇 |
妇产科学 | 9篇 |
基础医学 | 139篇 |
口腔科学 | 67篇 |
临床医学 | 122篇 |
内科学 | 281篇 |
皮肤病学 | 25篇 |
神经病学 | 62篇 |
特种医学 | 267篇 |
外科学 | 85篇 |
综合类 | 29篇 |
一般理论 | 1篇 |
预防医学 | 20篇 |
眼科学 | 427篇 |
药学 | 72篇 |
中国医学 | 3篇 |
肿瘤学 | 53篇 |
出版年
2023年 | 5篇 |
2022年 | 4篇 |
2021年 | 18篇 |
2020年 | 8篇 |
2019年 | 13篇 |
2018年 | 11篇 |
2017年 | 16篇 |
2016年 | 28篇 |
2015年 | 32篇 |
2014年 | 39篇 |
2013年 | 54篇 |
2012年 | 55篇 |
2011年 | 60篇 |
2010年 | 53篇 |
2009年 | 57篇 |
2008年 | 72篇 |
2007年 | 113篇 |
2006年 | 53篇 |
2005年 | 46篇 |
2004年 | 46篇 |
2003年 | 35篇 |
2002年 | 54篇 |
2001年 | 50篇 |
2000年 | 37篇 |
1999年 | 32篇 |
1998年 | 52篇 |
1997年 | 56篇 |
1996年 | 63篇 |
1995年 | 37篇 |
1994年 | 40篇 |
1993年 | 24篇 |
1992年 | 21篇 |
1991年 | 36篇 |
1990年 | 28篇 |
1989年 | 49篇 |
1988年 | 43篇 |
1987年 | 32篇 |
1986年 | 52篇 |
1985年 | 36篇 |
1984年 | 25篇 |
1983年 | 16篇 |
1982年 | 17篇 |
1981年 | 13篇 |
1980年 | 16篇 |
1979年 | 6篇 |
1978年 | 8篇 |
1977年 | 8篇 |
1976年 | 10篇 |
1975年 | 9篇 |
1968年 | 3篇 |
排序方式: 共有1712条查询结果,搜索用时 15 毫秒
41.
42.
Jacqueline J. O. N. van den Bosch Vincenzo Pennisi Azzurra Invernizzi Kaweh Mansouri Robert N. Weinreb Hagen Thieme Michael B. Hoffmann Lars Choritz 《Investigative ophthalmology & visual science》2021,62(6)
PurposeTo explore the effect of gaze direction and eyelid closure on intraocular pressure (IOP).MethodsEleven patients with primary open-angle glaucoma previously implanted with a telemetric IOP sensor were instructed to view eight equally-spaced fixation targets each at three eccentricities (10°, 20°, and 25°). Nine patients also performed eyelid closure. IOP was recorded via an external antenna placed around the study eye. Differences of mean IOP between consecutive gaze positions were calculated. Furthermore, the effect of eyelid closure on gaze-dependent IOP was assessed.ResultsThe maximum IOP increase was observed at 25° superior gaze (mean ± SD: 4.4 ± 4.9 mm Hg) and maximum decrease at 25° inferonasal gaze (−1.6 ± 0.8 mm Hg). There was a significant interaction between gaze direction and eccentricity (P = 0.003). Post-hoc tests confirmed significant decreases inferonasally for all eccentricities (mean ± SEM: 10°: −0.7 ± 0.2, P = 0.007; 20°: −1.1 ± 0.2, P = 0.006; and 25°: −1.6 ± 0.2, P = 0.006). Eight of 11 eyes showed significant IOP differences between superior and inferonasal gaze at 25°. IOP decreased during eyelid closure, which was significantly lower than downgaze at 25° (mean ± SEM: −2.1 ± 0.3 mm Hg vs. −0.7 ± 0.2 mm Hg, P = 0.014).ConclusionsOur data suggest that IOP varies reproducibly with gaze direction, albeit with patient variability. IOP generally increased in upgaze but decreased in inferonasal gaze and on eyelid closure. Future studies should investigate the patient variability and IOP dynamics. 相似文献
43.
Nancy?ByattEmail author Kathleen?Biebel Gifty?Debordes-Jackson Rebecca?S.?Lundquist Tiffany?A.?Moore Simas Linda?Weinreb Douglas?Ziedonis 《The Psychiatric quarterly》2013,84(2):169-174
This is the first study evaluating obstetrics and gynecology (OB/Gyn) provider and staff perceptions of barriers to accessing pharmacotherapy for perinatal depression outside the obstetric setting. Four, 90 min focus groups were conducted with OB/Gyn physicians, advance practice nurses, and support and nursing staff (n = 28). Data were analyzed with a grounded theory approach. Participants perceived that community mental health providers and pharmacists often do not want to participate in pharmacotherapy for perinatal women. Participants believed the solution is training for community mental health providers in the risks and benefits of pharmacotherapy for perinatal depression and improved communication between OB/Gyn’s and community mental health providers. Community mental health provider and pharmacist reluctance to provide pharmacotherapy hinders OB/Gyn’s perceived ability to address perinatal depression. Community mental health provider and pharmacist training are needed to mitigate precipitous discontinuation of treatment and to improve access to pharmacotherapy for perinatal women. 相似文献
44.
45.
Meredith L. Johnston MBBS Shao Hui Huang MSc John N. Waldron MD Eshetu G. Atenafu MSc Kelvin Chan MD MSc Bernard J. Cummings MBChB Ralph W. Gilbert MD David Goldstein MD Patrick J. Gullane MB Jonathan C. Irish MD MSc Bayardo Perez–Ordonez MD Ilan Weinreb MD Andrew Bayley MD John Cho MD PhD Laura A. Dawson MD Andrew Hope MD Jolie Ringash MD MSc Ian J. Witterick MD Brian O'Sullivan MD John Kim MD 《Head & neck》2016,38(Z1):E820-E826
46.
Impact of p16 expression,nodal status,and smoking on oncologic outcomes of patients with head and neck unknown primary squamous cell carcinoma 下载免费PDF全文
47.
Friedlander AH Weinreb J Friedlander I Yagiela JA 《Journal of the American Dental Association (1939)》2007,138(2):179-87; quiz 248
BACKGROUND: The dental literature contains little information about metabolic syndrome (MetS) and its dental implications. TYPES OF STUDIES REVIEWED: The authors conducted a MEDLINE search for the period 2000 through 2005, using the term "metabolic syndrome" to define its pathophysiology, medical treatment and dental implications. RESULTS: MetS is the co-occurrence of abdominal obesity, hyper-triglyceridemia, reduced high-density lipoprotein cholesterol levels, hypertension and impaired fasting glucose, which results from consumption of a high-calorie diet and decreased levels of physical activity superimposed on the appropriate genetic setting. Components of MetS synergistically promote the development of atherosclerosis, resulting in myocardial infarction and stroke. CLINICAL IMPLICATIONS: Deteriorating oral health status is associated with worsening of the atherogenic profile. Tooth loss often results in chewing difficulties because of inadequate occlusive surfaces and may lead to alterations in food selection and dietary quality. This, in turn, adversely affects body composition and nutritional status, both of which are related to vascular health. Dentists should develop treatment plans that preserve and restore the dentition, thus ensuring maximum masticatory efficiency and affording patients the optimum opportunity to consume food that will not foster atherogenesis. 相似文献
48.
Vadim Goz Jeffrey H. Weinreb Frank Schwab Virginie Lafage Thomas J. Errico 《The spine journal》2014,14(9):2019-2027
Background contextLumbar interbody fusion (LIF) techniques have been used for years to treat a number of pathologies of the lower back. These procedures may use an anterior, posterior, or combined surgical approach. Each approach is associated with a unique set of complications, but the exact prevalence of complications associated with each approach remains unclear.PurposeTo investigate the rates of perioperative complications of anterior lumbar interbody fusion (ALIF), posterior/transforaminal lumbar interbody fusion (P/TLIF), and LIF with a combined anterior-posterior interbody fusion (APF).Study design/settingRetrospective review of national data from a large administrative database.Patient samplePatients undergoing ALIF, P/TLIF, or APF.Outcome measuresPerioperative complications, length of stay (LOS), total costs, and mortality.MethodsThe Nationwide Inpatient Sample database was queried for patients undergoing ALIF, P/TLIF, or APF between 2001 and 2010 as identified via International Classification of Diseases, ninth revision codes. Univariate analyses were carried out comparing the three cohorts in terms of the outcomes of interest. Multivariate analysis for primary outcomes was carried out adjusting for overall comorbidity burden, race, gender, age, and length of fusion. National estimates of annual total number of procedures were calculated based on the provided discharge weights. Geographic distribution of the three cohorts was also investigated.ResultsAn estimated total of 923,038 LIFs were performed between 2001 and 2010 in the United States. Posterior/transforaminal lumbar interbody fusions accounted for 79% to 86% of total LIFs between 2001 and 2010, ALIFs for 10% to 15%, and APF decreased from 10% in 2002 to less than 1% in 2010. On average, P/TLIF patients were oldest (54.55 years), followed by combined approach (47.23 years) and ALIF (46.94 years) patients (p<.0001). Anterior lumbar interbody fusion, P/TLIF, and combined surgical costs were $75,872, $65,894, and $92,249, respectively (p<.0001). Patients in the P/TLIF cohort had the greatest number of comorbidities, having the highest prevalence for 10 of 17 comorbidities investigated. Anterior-posterior interbody fusion group was associated with the greatest number of complications, having the highest incidence of 12 of the 16 complications investigated.ConclusionsThese data help to define the perioperative risks for several LIF approaches. Comparison of outcomes showed that a combined approach is more expensive and associated with greater LOS, whereas ALIF is associated with the highest postoperative mortality. These trends should be taken into consideration during surgical planning to improve clinical outcomes. 相似文献
49.
Plasma levels of plasminogen activator inhibitor type-1 (PAI-1), beta- thromboglobulin (beta TG), and fibrinopeptide A (FPA) were followed over 24 hours in 30 patients treated with alteplase for acute myocardial infarction. Samples were taken at baseline (T Oh), after 90 minutes (under alteplase, no heparin, T 1.5h), after 120 minutes (under alteplase and heparin, T 2h), 30 minutes after thrombolytic therapy (T 3.5h), as well as 12 hours (T 12h) and 24 hours (T 24h) after baseline. PAI-1 antigen levels (55 +/- 9 ng/mL at T Oh, mean +/- SEM) decreased to 35 +/- 5 (T 1.5h) and 40 +/- 6 (T 2h) ng/mL under alteplase, before increasing to 84 +/- 22 (T 3.5h), 130 +/- 30 (T 12h), and 64 +/- 7 (T 24h) ng/mL after therapy, P less than .001. A high baseline PAI-1 activity (18 +/- 3 ng/mL) decreased to 2.0 +/- 0.4 (T 1.5h) and 1.7 +/- 0.2 (T 2h) under alteplase and increased to 32 +/- 5 (T 12h) and 19 +/- 3 (T 24h) ng/mL after therapy (P less than .0001). beta TG levels (339 +/- 105 ng/mL at T Oh) decreased to 203 +/- 48 (T 2h), 154 +/- 51 (T 3.5h), 187 +/- 40 (T 12h), and 142 +/- 32 (T 24h) ng/mL under heparin (P less than .01). FPA levels (34 +/- 9 ng/mL at T Oh) increased to 85 +/- 15 ng/mL under alteplase alone (T 1.5h) and normalized under heparin (11 +/- 4, 6 +/- 2, 4 +/- 2, and 3 +/- 1 ng/mL at T 2h, T 3.5h, T 12h, and T 24h, respectively). A high level of FPA at T 3.5h correlated with reocclusion (33 +/- 12 ng/mL, n = 4 v 2.9 +/- 0.5 ng/mL, n = 21, P less than .005). We conclude that plasma levels of PAI- 1 antigen as well as activity markedly increase after alteplase therapy of acute myocardial infarction. The high activity of PAI-1 and decreasing beta TG levels suggest that platelets do not contribute significantly to this phenomenon. The marked increase of FPA levels under recombinant tissue-type plasminogen activator alone and its normalization under heparin emphasize the important role of concomitant anticoagulation in controlling further intravasal fibrin generation under alteplase. 相似文献
50.
Prevalence of type 1 Gaucher disease in the United States 总被引:1,自引:0,他引:1
Weinreb NJ Andersson HC Banikazemi M Barranger J Beutler E Charrow J Grabowski GA Hollak CE Kaplan P Mankin H Mistry PK Rosenbloom BE Vom Dahl S Zimran A 《Archives of internal medicine》2008,168(3):326-7; author reply 327-8